Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-30

FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Mylan's original ANDA for a generic fixed-dose combination of amlodipine and valsartan for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

ORIG AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)